Review Article

Barium Sulfate Nanoparticles: Applications in Pharmaceuticals and Healthcare

Tianxing Cai*

Dan F Smith Department of Chemical and Biomolecular Engineering, Lamar University, Beaumont, USA

Submission: March 01, 2024; Published: April 10, 2024

*Corresponding author: Tianxing Cai, Dan F Smith Department of Chemical and Biomolecular Engineering, Lamar University, Beaumont, USA

How to cite this article: Tianxing Cai*. Barium Sulfate Nanoparticles: Applications in Pharmaceuticals and Healthcare. Curr Trends Biomedical Eng & Biosci. 2024; 22(4): 556093. DOI:10.19080/CTBEB.2024.22.556093

Abstract

Barium sulfate nanoparticles (BaSO4 NPs) have garnered significant attention in recent years due to their diverse applications in the field of pharmaceuticals and healthcare. This comprehensive review explores the various roles and potential benefits of BaSO4 NPs in these critical sectors. The unique properties of BaSO4 NPs, including their biocompatibility, stability, and inertness, make them attractive candidates for a range of applications. In pharmaceuticals, BaSO4 NPs are commonly employed as contrast agents in medical imaging techniques such as X-ray Computed Tomography (CT) scans and gastrointestinal tract imaging. Additionally, their use in drug delivery systems, nanomedicine, and theragnostic has shown promising results. In healthcare, BaSO4 NPs find utility in wound healing, tissue engineering, and diagnostic assays. This review provides an overview of the synthesis methods, characterization techniques, and current applications of BaSO4 NPs in pharmaceutical formulations and healthcare products. Furthermore, challenges and future perspectives for the widespread adoption of BaSO4 NPs in these fields are discussed, highlighting opportunities for further research and development.

Keywords: X-ray computed tomography; Gastrointestinal tract imaging; Biocompatibility and Stability; Crystallinity; Microemulsion techniques

Abbreviations: CT: Computed Tomography; TEM: Transmission Electron Microscopy; SEM: Scanning Electron Microscopy; XRD: X-Ray Diffraction; DLS: Dynamic light scattering

Introduction

Barium sulfate nanoparticles (BaSO4 NPs) have emerged as a versatile material with a wide range of applications in the pharmaceutical and healthcare industries [1-3]. Their unique properties, including high X-ray attenuation, biocompatibility, and stability, make them particularly attractive for a multitude of purposes within these fields [4,5]. BaSO4 NPs are increasingly recognized for their potential in enhancing medical imaging techniques, such as X-ray computed tomography (CT) scans and gastrointestinal tract imaging, where their ability to enhance contrast significantly improves diagnostic accuracy [4,5]. Moreover, their inertness and biocompatibility render them suitable for applications in drug delivery systems, where they can facilitate targeted delivery of therapeutics to specific tissues or organs, thereby improving efficacy and minimizing side effects [4,5].

This review paper aims to provide a comprehensive overview of the synthesis, characterization, and applications of BaSO4 NPs in pharmaceutical formulations and healthcare products. By elucidating the various synthesis methods available and detailing the characterization techniques employed to assess their quality and suitability, this paper aims to offer insights into the fundamental aspects of BaSO4 NP science. Additionally, it seeks to explore the diverse applications of BaSO4 NPs in pharmaceutical formulations, ranging from enhancing drug solubility to enabling theragnostic approaches that integrate diagnostic imaging with therapeutic interventions. Through this comprehensive examination, this review endeavors to contribute to the growing body of knowledge surrounding the utilization of BaSO4 NPs in advancing pharmaceutical and healthcare technologies.

Synthesis Methods

Several methods have been developed for the synthesis of BaSO4 NPs, reflecting the diverse needs and applications within the pharmaceutical and healthcare sectors [6,7]. Chemical precipitation, one of the most employed methods, involves the mixing of barium and sulfate ions in a suitable solvent under controlled conditions to induce the formation of BaSO4 nanoparticles [8,9]. This method offers simplicity, scalability, and cost-effectiveness, making it an attractive option for large-scale production [8,9]. Additionally, chemical precipitation allows for precise control over particle size and morphology through adjustments in reaction parameters such as temperature, pH, and stirring rate [6-9]. On the other hand, hydrothermal synthesis involves subjecting precursor materials to high temperatures and pressures in an aqueous solution, leading to the formation of BaSO4 nanoparticles [10,11]. This method offers advantages in terms of uniform particle size distribution and crystallinity, as well as the ability to produce nanoparticles with controlled surface properties [10,11]. However, it typically requires specialized equipment and longer reaction times, limiting its scalability for industrial applications [10,11].

Microemulsion techniques represent another approach to BaSO4 NP synthesis, wherein a surfactant-stabilized microemulsion system is utilized to control nucleation and growth processes [12,13]. This method allows to produce BaSO4 nanoparticles with narrow size distributions and well-defined morphologies by adjusting the composition and properties of the microemulsion system [14,15]. Moreover, microemulsion techniques offer advantages in terms of reproducibility, stability, and the ability to encapsulate functional molecules within the nanoparticles for targeted drug delivery applications [16,17]. Despite these advantages, microemulsion-based synthesis methods may pose challenges in terms of scalability and the need for precise control over experimental parameters [14-17]. Overall, the choice of synthesis method for BaSO4 NPs depends on various factors, including the desired particle characteristics, intended applications, and available resources [14-17]. By understanding the strengths and limitations of each synthesis approach, researchers can make informed decisions to optimize the production of BaSO4 nanoparticles for pharmaceutical and healthcare applications [14-17].

Characterization Techniques

Characterization of BaSO4 NPs plays a crucial role in verifying their quality and determining their suitability for diverse pharmaceutical and healthcare applications [18-21]. A range of analytical techniques is employed to gain insights into the physical and chemical properties of these nanoparticles, ensuring their performance and safety in various contexts [18-21]. Transmission electron microscopy (TEM) enables researchers to visualize the morphology and size of individual BaSO4 nanoparticles at the nanoscale, providing valuable information about their shape, structure, and uniformity [22,23]. Additionally, scanning electron microscopy (SEM) offers complementary imaging capabilities, allowing for high-resolution surface analysis and threedimensional reconstructions of BaSO4 NP aggregates [24,25]. These microscopy techniques are instrumental in characterizing the structural features of BaSO4 NPs and assessing their suitability for specific applications, such as drug delivery or medical imaging [18-25].

Moreover, X-ray diffraction (XRD) is utilized to investigate the crystalline structure of BaSO4 nanoparticles, providing insights into their composition and phase purity [19-26]. By analyzing the diffraction patterns generated by the interaction of X-rays with the crystal lattice of BaSO4 NPs, researchers can identify crystallographic phases and quantify crystallite sizes with precision [19-26]. Dynamic light scattering (DLS) represents another valuable technique for characterizing BaSO4 NP dispersions in solution, allowing for the measurement of particle size distributions and colloidal stability [27,28]. By elucidating the physical properties and behavior of BaSO4 nanoparticles under different conditions, comprehensive characterization efforts contribute to the optimization of their formulation and performance in pharmaceutical and healthcare applications [19- 28].

Applications in Pharmaceuticals

BaSO4 NPs have garnered widespread recognition for their pivotal role as contrast agents in various medical imaging modalities, notably X-ray computed tomography (CT) scans and gastrointestinal tract imaging [29,30]. Leveraging their remarkable X-ray attenuation properties and biocompatibility, BaSO4 NPs serve as indispensable tools for enhancing the visualization of anatomical structures and facilitating the accurate diagnosis of medical conditions [29,30]. Their ability to selectively absorb X-rays enables clinicians to obtain high-resolution images with enhanced contrast, thereby improving diagnostic accuracy and patient outcomes [29,30].

Beyond their utility in medical imaging, BaSO4 NPs are the subject of extensive investigation for their potential applications in drug delivery systems, nanomedicine, and theragnostic [31]. By capitalizing on their unique physicochemical properties, BaSO4 NPs offer promising avenues for overcoming challenges associated with conventional drug delivery methods [32]. These nanoparticles have demonstrated the ability to enhance drug solubility, prolong circulation time, and target specific tissues or cells, thereby improving therapeutic efficacy and minimizing systemic side effects [33]. Moreover, the integration of BaSO4 NPs into theragnostic platforms holds considerable potential for advancing personalized medicine approaches, enabling simultaneous imaging and therapy to facilitate real-time monitoring of treatment response and disease progression [34]. Through ongoing research efforts, BaSO4 NPs continue to emerge as versatile tools with transformative potential across diverse biomedical applications, driving innovation and advancing the frontiers of healthcare [29-34].

Application in Healthcare

In addition to their pivotal role in pharmaceutical formulations, BaSO4 NPs exhibit versatile applications across various healthcare domains, contributing to advancements in wound healing, tissue engineering, and diagnostic assays [35]. Their innate inertness and biocompatibility render BaSO4 NPs well-suited for integration into a wide array of medical devices, implants, and diagnostic tools, offering enhanced functionality and biocompatible interactions within biological systems [36-38]. By leveraging the unique physicochemical properties of BaSO4 NPs, researchers have been able to develop innovative solutions for addressing complex healthcare challenges, ranging from tissue regeneration to disease diagnosis and treatment monitoring [36- 38].

Furthermore, the antimicrobial properties inherent in BaSO4 NPs present promising opportunities for combating infections and fostering wound healing in clinical settings [39-41]. Through their ability to inhibit microbial growth and promote tissue regeneration, BaSO4 NPs offer a multifaceted approach to wound care applications, addressing both the prevention and treatment of infections [39-41]. As research in this area continues to evolve, the integration of BaSO4 NPs into wound dressings, implants, and other medical devices holds significant potential for improving patient outcomes and reducing healthcare-associated infections, underscoring their growing importance in the broader landscape of healthcare innovation [42].

Challenges and Future Perspectives

Despite the promising applications of BaSO4 NPs in pharmaceuticals and healthcare, several challenges remain to be addressed [43-45]. These include concerns regarding biocompatibility, toxicity, and long-term effects on human health [43-45]. Furthermore, the scalability and cost-effectiveness of synthesis methods need to be improved to facilitate large-scale production and commercialization of BaSO4 NPs-based products [46]. Nonetheless, ongoing research efforts are expected to overcome these challenges and unlock new opportunities for the widespread adoption of BaSO4 NPs in medical and healthcare settings.

Conclusion

In conclusion, BaSO4 nanoparticles offer significant potential for enhancing pharmaceutical formulations and healthcare products. Their unique properties, including high X-ray attenuation, biocompatibility, and stability, make them attractive candidates for various applications, ranging from medical imaging to drug delivery and therapeutic interventions. Despite existing challenges, continued research and development efforts are expected to drive innovation and foster the adoption of BaSO4 NPs in pharmaceuticals and healthcare, ultimately improving patient outcomes and advancing medical science.

References

1. Mhatre S, Naik S, Patravale V (2021) Exploring green and industrially scalable Microfluidizer™ technology for development of barium sulphate nanosuspension for enhanced contrasting. J Drug Delivery Sci Tech 64: 102567.
2. Shukla A, Kuamr S (2023) Development of Carrageenan-Linked Barium Sulphate Nanoparticles for Selective Tumor Cell Diagnosis and Treatment p. 16.
3. Abdullah Rahman, AU, Faisal S, Almostafa MM, Younis NS, Yahya G (2023) Multifunctional spirogyra-hyalina-mediated barium oxide nanoparticles (BaONPs): synthesis and applications. Molecules 28(17): 6364.
4. Sneha KR, Sailaja GS (2021) Intrinsically radiopaque biomaterial assortments: a short review on the physical principles, X-ray imageability, and state-of-the-art developments. J Mat Chem B 9(41): 8569-8593.
5. Chen H, Rogalski MM, Anker JN (2012) Advances in functional X-ray imaging techniques and contrast agents. Phys Chem Chem Phys 14(39): 13469-13486.
6. Abdulla SAE (2010) Barium Sulphate: Problems, Solutions and Applications. University of Surrey (United Kingdom).
7. Castro L, Blázquez ML, González FG, Ballester A (2014) Mechanism and applications of metal nanoparticles prepared by bio-mediated process. Rev Adv Sci Engineer 3(3): 199-216.
8. Ketegenov T, Kamunur K, Batkal A, Gani D, Nadirov R (2022) Recent advances in the preparation of barium sulfate nanoparticles: a mini review. Chem Engineering 6(2): 30.
9. Adityawarman D (2007) Precipitation of barium sulphate nanoparticles in microemulsion: Experiments and modelling (Doctoral dissertation, Otto-von-Guericke-Universität Magdeburg).
10. Liu C, Shaw L (2015) Nanoparticulate materials and core/shell structures derived from wet chemistry methods. Encyclopedia of Nanotechnology. Dordrecht: Springer Netherlands p. 1-21.
11. Srivastava S, Bhargava A, Srivastava S, Bhargava A (2022) Green synthesis of nanoparticles. Green Nanoparticles: The Future of Nanobiotechnology p. 53-75.
12. Sanyal A (2006) Use of inorganic composites for the synthesis of nanoparticles.
13. Björkegren S (2019) Exploring functionalization of colloidal silica for nanoparticle-stabilized emulsions. Chalmers Tekniska Hogskola (Sweden).
14. Ramaswamy V, Vimalathithan RM, Ponnusamy V (2010) Synthesis and characterization of BaSO₄ nano particles using micro emulsion technique. Adv Appl Sci Res 1(3): 197-204.
15. Qi L, Ma J, Cheng H, Zhao Z (1996) Preparation of BaSO₄ nanoparticles in non-ionic w/o microemulsions. Colloids and Surfaces A: Physicochem Engineer Aspects 108(1): 117-126.
16. Koetz J, Andres S, Kosmella S, Tiersch B (2006) BaSO₄ nanorods produced in polymer-modified bicontinuous microemulsions. Composite Interfaces 13(4-6): 461-475.
17. Iida S, Shoji T, Obatake N, Sato H, Ohgaki K (2005) Formation of BaSO₄ whiskers in microemulsion. J Chem Engineer Japan 38(5): 357-359.
18. Al-wdan, OA, Sharallah OA, Abdelwahab NA, Mohammed AO, Elmowafy E, et al. (2023) Insights into microfabrication and implementation of microfluidics in pharmaceutical drug delivery and analysis. Open Nano 12: 100156.
19. Ahmadzadeh M, Mirzaei M, Sabouri Z, Darroudi M (2024) Assessment of the photocatalytic performance and cytotoxic effects of barium sulfate nanoparticles synthesized with a one-step hydrothermal method. Inorganic Chemistry Communications 160: 111904.
20. Ragelienė L, Paulauskaitė R, Trečiokaitė L, Žūkienė R, Daugelavičius R, et al. (2020) Impact of BaSO₄ Particles on the Viability of Eukaryotic and Prokaryotic Cells. J Pharmacy & Pharmacology 8(12): 361-373.
21. Al-wdan OA, Sharallah OA, Abdelwahab NA, Mohammed AO, Elmowafy E, et al. (2023) Insights into microfabrication and implementation of microfluidics in pharmaceutical drug delivery and analysis. Open Nano 12: 100156.
22. Ketegenov T, Kamunur K, Batkal A, Gani D, Nadirov R (2022) Recent advances in the preparation of barium sulfate nanoparticles: a mini review. Chem Engineer 6(2): 30.
23. Hopwood JD, Mann S (1997) Synthesis of barium sulfate nanoparticles and nanofilaments in reverse micelles and microemulsions. Chem Materials 9(8): 1819-1828.
24. Sivakumar S, Soundhirarajan P, Venkatesan A, Khatiwada CP (2015) Synthesis, characterization and anti-bacterial activities of pure and Co-doped BaSO₄ nanoparticles via chemical precipitation route. Spectrochim Acta Part A: Mol Biomol Spectrosc 137: 137-147.
25. Ragelienė L, Paulauskaitė R, Trečiokaitė L, Žūkienė R, Daugelavičius R, et al. (2020) Impact of BaSO₄ Particles on the Viability of Eukaryotic and Prokaryotic Cells. J Pharmacy & Pharmacology 8(12): 361-373.
26. Sivakumar S, Soundhirarajan P, Venkatesan A, Khatiwada CP (2015) Synthesis, characterization and anti-bacterial activities of pure and Co-doped BaSO₄ nanoparticles via chemical precipitation route. Spectrochim Acta Part A: Mol Biomol Spectrosc 137: 137-147.
27. Reissig F, Zarschler K, Hübner R, Pietzsch HJ, Kopka K, et al. (2020) Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy.Chemistry Open 9(8): 797-805.
28. Reissig F, Hübner R, Steinbach J, Pietzsch HJ, Mamat C (2019) Facile preparation of radium-doped, functionalized nanoparticles as carriers for targeted alpha therapy. Inorg Chem Front 6(6): 1341-1349.
29. Attia MF, Wallyn J, Anton N, Vandamme TF (2018) Inorganic nanoparticles for X-ray computed tomography imaging. Crit Rev Ther Drug Carrier Syst 35(5).
30. Zavestovskaya I, Kabashin A, Petriev V (2019) Advanced Technologies of Nuclear Nano Medicine and Radiotherapy. Physics, Engineering and Technologies for Biomedicine. The 4th International Sym 9(1): 53.
31. Huang RH (2023) Design and Synthesis of Surface-Functionalized Nanomaterials for Cancer Theranostics, Doctoral dissertation, City University of New York.
32. Li Z, Di C, Li S, Yang X, Nie G (2019) Smart nanotherapeutic targeting of tumor vasculature. Acc Chem Res 52(9): 2703-2712.
33. Mishra D, Hubenak JR, Mathur AB (2013) Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. J Biomed Mater Res Part A: 101(12): 3646-3660.
34. Saluja V, Mishra Y, Mishra V, Giri N, Nayak P (2021) Dendrimers based cancer nanotheranostics: An overview. Int J Pharm 600: 120485.
35. Takallu S, Mirzaei E, Zakeri Bazmandeh A, Ghaderi Jafarbeigloo HR, Khorshidi H (2024) Addressing Antimicrobial Properties in Guided Tissue/Bone Regeneration Membrane: Enhancing Effectiveness in Periodontitis Treatment. ACS Infect Dis 10(3): 779-807.
36. Kader MS (2023) Synthesis of Various Nanocomposites for Applications in Biomedical Imaging and Energy Storage (Doctoral dissertation, Saint Louis University).
37. Hildebrandt N, Charbonnière L (2020) Lanthanide nanoparticles and their biological applications. Rare Earth Chemistry, ed. R. Pöttgen, T Jüstel and CA Strassert, Berlin, Boston: De Gruyter 525-536.
38. Attia MF, Wallyn J, Anton N, Vandamme TF (2018) Inorganic nanoparticles for X-ray computed tomography imaging. Crit RevThera Drug Carrier Syst 35(5): 391-431.
39. Takallu S, Mirzaei E, Zakeri Bazmandeh A, Ghaderi Jafarbeigloo HR, et al. (2024) Addressing Antimicrobial Properties in Guided Tissue/Bone Regeneration Membrane: Enhancing Effectiveness in Periodontitis Treatment. ACS Infectious Diseases 10(3): 779-807.
40. Mesquita MQ, Dias CJ, Neves MG, Almeida A, Faustino MAF (2018) Revisiting current photoactive materials for antimicrobial photodynamic therapy. Molecules 23(10): 2424.
41. Wang S, Gao Y, Jin Q, Ji J (2020) Emerging antibacterial nanomedicine for enhanced antibiotic therapy. Biomaterials Sci 8(24): 6825-6839.
42. Doser M (2023) Particles for medical textiles. Particle Technology and Textiles: Review of Applications 275.
43. Mohammadpour R, Dobrovolskaia MA, Cheney DL, Greish KF, Ghandehari H (2019) Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications. Adv Drug Deliv Rev 144: 112-132.
44. Naseri N, Ajorlou E, Asghari F, Pilehvar-Soltanahmadi Y (2018) An update on nanoparticle-based contrast agents in medical imaging. Artif Cells nanomed Biotech 46(6): 1111-1121.
45. Agrahari V, Burnouf PA, Burnouf T, Agrahari V (2019) Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential. Adv Drug Deliv Rev 148: 146-180.
46. Wallyn J, Anton N, Akram S, Vandamme TF (2019) Biomedical imaging: principles, technologies, clinical aspects, contrast agents, limitations and future trends in nanomedicines. Pharm Res 36(6): 1-31.